Medable Inc.
Location
California
Founded
2012-02-26
Website
Risk Signals
29 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Prepackaged Software), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Medable Inc.
Live alerts from global media, monitored by Business Radar
2025-04-08 (clinicalleader.com)
Case Study Setting A New Client Standard In Study Closeout Timelines
Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
Read more
2025-03-27 (appliedclinicaltrialsonline.com)
Addressing Clinical Trial Challenges Through AI and Scalable Solutions
Andrew Mackinnon, Executive GM, Medable, discusses how AI-driven innovations are streamlining clinical trials through enabling scalable operations.
Read more
2025-03-25 (appliedclinicaltrialsonline.com)
Medable Eyes Expanded Presence in Europe with New Approval for Digital Trials
Andrew Mackinnon, Executive GM, Medable, explains how the company's recent approval in France could support the expansion of digital and decentralized clinical trials across Europe, particularly through enhanced e-consent practices.
Read more
2025-03-21 (appliedclinicaltrialsonline.com)
Enhancing Patient Engagement and Data Accuracy in Decentralized Trials
Andrew Mackinnon, executive GM, Medable, explains how the company ensures high patient participation and data accuracy in decentralized trials.
Read more
2025-03-11 (clinicalleader.com)
GSK And Medable Discuss The Next Phase Of DCTs
GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.
Read more
2025-03-04 (siliconcanals.com)
Medable obtains the historical approval of CNIL, expanding access to digital clinical experiments throughout the European Union -
Palo Alto, California-(Business Wire)-Medable Inc., leading technology supplier for clinical development, announced that its Econsent and Ecoa solutions were
Read more
2025-02-05 (appliedclinicaltrialsonline.com)
SCOPE Summit 2025: Pamela Tenaerts of Medable Discusses Research From PACT Consortium Linking DCTs and Increased Diversity
In an interview with ACT senior editor Andy Studna at SCOPE Summit, Tenaerts, chief scientific officer, Medable, highlights the recent findings and how decentralized elements can improve access to underrepresented populations.
Read more
2025-01-29 (biospace.com)
Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption -
Growing industry confidence drives shift in digital strategy for clinical trial sponsors
Read more
2025-01-28 (oudaily.com)
City council candidates address housing, homeless services | News | oudaily.com
Editor's Note: This article was updated at 2:40 p.m. on Jan. 30 to remove a statement incorrectly claiming that Sandra Artman moved to Norman in 2022.
Read more